NCL applauds FDA nomination of Robert Califf

November 15, 2021

Media contact: National Consumers League – Carol McKay, or (412) 945-3242

Washington, DC—The National Consumers League extends congratulations to Dr. Robert Califf for his nomination to serve as Commissioner of the U.S. Food and Drug Administration. As COVID-19 persists and the nation continues to face unprecedented public health challenges, consumers rely on the FDA to ensure the safety and efficacy of our food and prescription drug supply.

NCL Executive Director Sally Greenberg weighed in with the following statement:

“NCL welcomes Dr. Robert Califf to the important role as Commissioner of the FDA. We have worked with Dr. Califf during previous administrations and can attest that he brings a longstanding commitment to FDA’s crucial role of overseeing the nation’s food and drug industry as well as medical devices and cosmetics. Dr. Califf has a long list of priorities ahead of him, and it is our hope that we can look forward to working with him on matters of consumer protection.

Among NCL’s consumer safety concerns is the proliferation of unregulated CBD products in the marketplace, encouraging confidence in vaccines for the prevention of COVID-19 and other infectious diseases, ensuring accurate food and nutrition labeling information for consumers, and making prescription drugs accessible and affordable for all Americans.

NCL worked productively with Dr. Califf during his previous appointment as FDA commissioner, and we look forward to continuing to serve as a resource to the FDA under his leadership to ensure that both patient and consumer protection remain the highest priority.”


About the National Consumers League

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit